Can-Fite Biopharma Overview

Can-Fite Biopharma EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CANF.

Quarterly EBIT

-$2.53M

↓ 25.17% YoY

As of Dec 31, 2025

Annual EBIT (TTM)

-$9.95M

↓ 22.39% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin